1992
DOI: 10.1254/jjp.60.315
|View full text |Cite
|
Sign up to set email alerts
|

Protective Activity of Silipide on Liver Damage in Rodents

Abstract: ABSTRACT-The activity of silipide, a silybin-phosphatidylcholine complex (IdB 1016), was tested in different models of liver damage in rodents. After oral administration, silipide exhibited a significant and dose-related protective effect against the hepatotoxicity induced by CC14, praseodymium, ethanol and galactosamine. The ED50 values for inhibition of the rise in ASAT and ALAT levels caused by CC14 and praseodymium and for antagonism of the increase in liver triglycerides caused by ethanol ranged from 93 t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
16
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(18 citation statements)
references
References 21 publications
2
16
0
Order By: Relevance
“…Our previous works on hesperitin (21), quercetin (22), and curcumin (35) show that the hepatoprotective activity Values are means ± SD of these phytomolecules was improved by the phospholipid complexation in a dose-dependent manner. Silipide (a silybin-phospholipid complex) was found to improve the hepatoprotection of silybin both in human and animal models (36,37). In the present study, GA-HSPC complex showed better efficacy in comparison with pure molecule-treated group as well as group receiving physical mixture of GA and HSPC.…”
Section: Pharmacokinetic Parameterssupporting
confidence: 48%
“…Our previous works on hesperitin (21), quercetin (22), and curcumin (35) show that the hepatoprotective activity Values are means ± SD of these phytomolecules was improved by the phospholipid complexation in a dose-dependent manner. Silipide (a silybin-phospholipid complex) was found to improve the hepatoprotection of silybin both in human and animal models (36,37). In the present study, GA-HSPC complex showed better efficacy in comparison with pure molecule-treated group as well as group receiving physical mixture of GA and HSPC.…”
Section: Pharmacokinetic Parameterssupporting
confidence: 48%
“…Given that silybin is lipidincompatible, the combination with phosphatidylcholine facilitates passage of the flavonoid through biological membranes [7]. Some workers have reported on the protective effect of Siliphos ® against carbon tetrachloride, acetaminophen, alcohol and mushroom poisoning [7,[34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…The first three RE decreased RNA polymerase II activity while the latter three RE increased the activity; only Pr and Nd nitrates decreased RNA polymerase I activity while the other four did not change the RNA polymerase I activity. Otherwise, the biochemical changes are consistent among RE; those biochemical changes are increase in triglyceride in the liver (105,110,113,117) and increases in leakage of hepatic enzymes into blood (46,105,(111)(112)(113)(114)(115)(116). RE-induced hepatic injury seems to reduce P450 content and P450-related enzyme activities in rat (113) and mouse (109,119); however, the decreases in P450 activities (coumarin 7-hydroxylase and 7-ethoxyresorufin O-deethylase) at 3 to 4 days after iv injection of CeCI3 were preceded by increases in these enzyme activities at 1 to 2 days postinjection in DBA/2 mice (109,119).…”
Section: Exposure To Rare Earthsmentioning
confidence: 94%